BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29107349)

  • 1. Prognostic significance of lymphadenectomyin malignant ovarian sex cord stromal tumor: A retrospective cohort study and meta-analysis.
    Cheng H; Peng J; Yang Z; Zhang G
    Gynecol Oncol; 2018 Jan; 148(1):91-96. PubMed ID: 29107349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of lymph node metastasis and prognostic significance of lymphadenectomy in apparent early-stage malignant ovarian sex cord-stromal tumors.
    Nasioudis D; Kanninen TT; Holcomb K; Sisti G; Witkin SS
    Gynecol Oncol; 2017 May; 145(2):243-247. PubMed ID: 28292524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
    Wang J; Li J; Chen R; Lu X
    Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of metastasis in sex cord-stromal tumors of the ovary: can routine staging lymphadenectomy be omitted?
    Brown J; Sood AK; Deavers MT; Milojevic L; Gershenson DM
    Gynecol Oncol; 2009 Apr; 113(1):86-90. PubMed ID: 19162310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.
    Bilici A; Inanc M; Ulas A; Akman T; Seker M; Babacan NA; Inal A; Bal O; Koral L; Sevinc A; Tufan G; Elkiran ET; Ustaalioglu BB; Yavuzsen T; Alkis N; Ozkan M; Gumus M
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6493-9. PubMed ID: 24377556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feto-maternal outcomes of pregnancy complicated by ovarian sex-cord stromal tumor: a systematic review of literature.
    Blake EA; Carter CM; Kashani BN; Kodama M; Mabuchi S; Yoshino K; Matsuo K
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():1-7. PubMed ID: 24439718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis.
    Chan JK; Zhang M; Kaleb V; Loizzi V; Benjamin J; Vasilev S; Osann K; Disaia PJ
    Gynecol Oncol; 2005 Jan; 96(1):204-9. PubMed ID: 15589602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women.
    Zhang M; Cheung MK; Shin JY; Kapp DS; Husain A; Teng NN; Berek JS; Osann K; Chan JK
    Gynecol Oncol; 2007 Feb; 104(2):396-400. PubMed ID: 17030354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility sparing surgery for ovarian sex cord stromal tumors: a nine case series.
    Ghalleb M; Bouzaiene H; Sghaier S; Bouaziz H; Hechiche M; Hassouna JB; Rahal K
    Pan Afr Med J; 2018; 31():221. PubMed ID: 31447979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic management of early-stage malignant nonepithelial ovarian tumors: surgical and survival outcomes.
    Shim SH; Kim DY; Lee SW; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2013 Feb; 23(2):249-55. PubMed ID: 23318909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Fertility-Sparing Surgery for Premenopausal Women With Sex Cord-Stromal Tumors Confined to the Ovary.
    Nasioudis D; Frey MK; Chapman-Davis E; Witkin SS; Holcomb K
    Int J Gynecol Cancer; 2017 Nov; 27(9):1826-1832. PubMed ID: 28930803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph-node metastasis in stage I and II sex cord stromal and malignant germ cell tumours of the ovary: a systematic review.
    Kleppe M; Amkreutz LC; Van Gorp T; Slangen BF; Kruse AJ; Kruitwagen RF
    Gynecol Oncol; 2014 Apr; 133(1):124-7. PubMed ID: 24440833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The individualized significance of lymphadenectomy across all age groups and histologies in malignant ovarian germ cell tumors.
    Wang J; Chen R; Li J; Lu X
    Arch Gynecol Obstet; 2020 Dec; 302(6):1441-1450. PubMed ID: 32888090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunohistochemical and molecular analysis of problematic and unclassified ovarian sex cord-stromal tumors.
    Stewart CJ; Alexiadis M; Crook ML; Fuller PJ
    Hum Pathol; 2013 Dec; 44(12):2774-81. PubMed ID: 24134930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
    Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
    Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salomé study including 469 patients. A TMRG and GINECO group study.
    Hanvic B; Lecuru F; Vanacker H; Pautier P; Narducci F; Cherifi F; Floquet A; Angeles MA; Berton D; Pomel C; Kalbacher E; Provansal M; Fernandez Y; Rouge TM; Roméo C; Laas E; Morice P; Hudry D; Meriaux E; Guyon F; Illac-Vauquelin C; Selle F; Meeus P; Genestie C; Salleron J; Ray-Coquard I
    Gynecol Oncol; 2023 Jul; 174():190-199. PubMed ID: 37210929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and survival of patients with malignant ovarian sex cord-stromal cell tumours: An analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) study group CORSETT database.
    Klar M; Plett H; Harter P; Heitz F; Kommoss S; Hartkopf AD; Grube M; Roser E; Sehouli J; Braicu I; Czogalla B; Burges A; Bossart M; Hasanov MF; Link T; Staebler A; Mayr D; Buderath P; Hasenburg A
    J Surg Oncol; 2023 Jul; 128(1):111-118. PubMed ID: 36975108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
    Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
    Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.
    Al-Agha OM; Huwait HF; Chow C; Yang W; Senz J; Kalloger SE; Huntsman DG; Young RH; Gilks CB
    Am J Surg Pathol; 2011 Apr; 35(4):484-94. PubMed ID: 21378549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression and anxiety in women with malignant ovarian germ cell (MOGCT) and sex cord stromal tumors (SCST): an analysis of the AGO-CORSETT database.
    Bossart M; Plett H; Krämer B; Braicu E; Czogalla B; Klar M; Singer S; Mayr D; Staebler A; du Bois A; Kommoss S; Link T; Burges A; Heitz F; Grube M; Trillsch F; Harter P; Wimberger P; Buderath P; Hasenburg A
    Arch Gynecol Obstet; 2023 Apr; 307(4):1155-1162. PubMed ID: 36127525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.